glucuronic acid has been researched along with Bowel Diseases, Inflammatory in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bose, A; Md Ramli, SH; Naharudin, I; Wong, TW | 1 |
Cui, YL; Gao, LN; Wang, GF; Wang, QS; Zhou, J | 1 |
2 other study(ies) available for glucuronic acid and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Coatless alginate pellets as sustained-release drug carrier for inflammatory bowel disease treatment.
Topics: Alginates; Animals; Calcium Phosphates; Chemistry, Pharmaceutical; Colon; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Excipients; Female; Gastric Acid; Glucuronic Acid; Hexuronic Acids; Hydrophobic and Hydrophilic Interactions; Inflammatory Bowel Diseases; Rats; Rats, Sprague-Dawley; Solubility; Tablets | 2016 |
Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
Topics: Alginates; Animals; Biological Availability; Chitosan; Colitis, Ulcerative; Colon; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Flavonoids; Glucuronic Acid; Hexuronic Acids; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Microspheres; Rats; Rats, Sprague-Dawley; Solubility; Trinitrobenzenesulfonic Acid | 2016 |